Overall, our results suggest that intracellular Ca2+-related ERK1/2 signaling pathway attenuates dexamethasone sensitivity and apoptosis in ALL cells by decreasing Δψm collapse, ROS production, cytochrome c release from mitochondria, and caspase-3 activation. The gene discussed is CYCS; the disease is acute lymphoblastic leukemia.